[UPDATED 2022] BPS BPS-Pharmacotherapy Questions Prepare with Free Demo of PDF [Q14-Q34]

NO.14 In a clinical trial, when would “intention to treat” analysis be most appropriate?

NO.15 A 58-year-old woman presents to the emergency department of a small rural hospital with recurrent chest pain that is unrelieved by three sublingual nitroglycerin tablets. Initial evaluation of her ECG and cardiac enzymes are consistent with non-STEMI. The woman is admitted for observation and given aspirin. Which of the following should be added to this patient’s regimen to reduce her risk of death, MI, and recurrent ischemia?

NO.16 A postmenopausal patient with osteoporosis is being switched from conjugated estrogen to raloxifene treatment. Which of the following should be communicated to this patient as the best outcome that has been documented with raloxifene?

NO.17 In designing a clinical trial, the method utilized to deal with inherent differences between groups is to:

NO.18 The pharmacotherapy specialist-directed research team in a large healthcare system plans to submit a comparative effectiveness study proposal in response to the request for proposals released under the Patient Protection and Affordable Care Act. In designing this study, which category of outcomes should be used for the primary endpoint?

NO.19 Which program model may include a shared savings contract between a healthcare provider organization and the Centers for Medicare and Medicaid Services?

NO.20 When low molecular weight heparin is prescribed, in which of the following patient populations would monitoring anti-factor-Xa levels be reasonable to consider?

NO.21 A 58-year-old patient presents to a clinic for a routine physical. The patient has no significant past medical history. A recent visit to the primary care physician revealed the following fasting laboratory values:
* Glucose: 120 mg/dL
* TSH: 2.5 ulU/mL
* Total cholesterol: 256 mg/dL
* HDL cholesterol: 36 mg/dL
* LDL cholesterol: 170 mg/dL
* Triglycerides: 250 mg/dL
The patient would like to initiate alternative therapy in addition to the physician’s diet and exercise recommendations. Which of the following alternative products may be effective for this patient?

NO.22 A 60-year-old man who is HIV-positive describes symptoms of erectile dysfunction and requests therapy. Current medications include tenofovir 300 mg orally daily, emtricitabine 200 mg orally daily, atazanavir 300 mg orally daily, and ritonavir 100 mg orally daily. In addition to counseling on preventing HIV transmission, which recommendation is appropriate?

NO.23 A patient with renal failure is being treated with phenytoin and has an albumin concentration of
1.7 g/dL. Which of the following is likely to be higher than the general population in this patient?

NO.24 A 46-year-old man comes into the clinic complaining of facial swelling and difficulty breathing.
Upon examination, it is determined that the patient has facial edema most likely associated with enalapril use. The patient was transferred to the hospital for treatment of the facial edema. It is most appropriate to report this reaction to the:

NO.25 A pharmacotherapy specialist is evaluating a study that compared the effects of iron sucrose versus sodium ferric gluconate on ferritin levels in patients receiving hemodialysis. A significant difference was found between the groups. This study was conducted in a large academic center in Denmark; the specialist practices at a small rural hospital in Minnesota. Which of the following information in the paper will be most important in determining whether the study’s results can be applied to the specialist’s practice?

NO.26 Which statement best describes current recommendations on postnatal corticosteroids in neonatal Broncho pulmonary dysplasia?

NO.27 A patient taking warfarin is seen in the clinic today and prescribed a 2-Week course of fluconazole for a fungal infection. Before the patient receives the first dose of fluconazole, the pharmacotherapy specialist should ensure that:

NO.28 A patient with diabetic ketoacidosis is receiving 0.9% NaCl, with potassium chloride 20 mEq/L, at 200 mL/h, and regular insulin 8 units/h, intravenously. After 8 hours, the blood glucose is
250 mg/dL and the anion gap is elevated. At this point, which of the following is the most appropriate therapy?

NO.29 A 58-year-old patient is admitted to the hospital with a temperature of 38.3°C, cough, and dyspnea. Rales are present at the left base, and chest X-ray reveals a left lower lobe infiltrate.
Oxygen saturation is 88% on room air. Which of the following antibiotics is most appropriate?

NO.30 A 70-year-old 45-kg patient is admitted to the ICU with a diagnosis of digoxin intoxication. The patient complains of nausea, blurred vision, and fatigue that have been present for 3 days. A cardiac monitor reveals a HR of 42 bpm, an irregular rhythm, and a type second-degree heart block. Current medications include digoxin 0.25 mg and furosemide 40mg for heart failure, both taken daily at 0800. The patient remains adherent to all medications despite nausea, including today’s doses. Blood is drawn at 1200 with the following results:
* Potassium: 6.0 mEq/L
* Creatinine: 2.3 mg/dL
* Digoxin: 1.7 ng/mL
Which of the following most appropriately describes the patient’s digoxin concentration?

NO.31 Which of the following sources is most likely to publish the current recommendations from the Centers for Disease Control and Prevention regarding the use of recombinant hepatitis B Vaccine?

NO.32 A patient presents with palpitations and shortness of breath. A 12-lead ECG reveals a regular narrow QRS complex supraventricular tachycardia. What is the recommended first-line therapy?

NO.33 A 72-year-old man has chronic insomnia that has not responded to measures to improve sleep hygiene. The patient is not depressed and has no other chronic health problems. It is determined that medication use will probably be necessary to manage the insomnia. What is the best initial recommendation for this patient?

NO.34 With regard to the privacy rule of the Health Insurance Portability and Accountability Act (HIPAA), which of the following statements is correct with regard to the use or disclosure of Protected Health Information (PHI) in clinical research?